Top FDA gene and cell therapy regulator to step down
Vijay Kumar, a prominent figure in the FDA’s gene and cell therapy division, is set…
Newswire
Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
Amgen’s rare disease treatment, Tavneos, faces a significant setback following the retraction of its pivotal…
AstraZeneca to Pay $34 Million to Settle Kickback Allegations in Texas
AstraZeneca has agreed to pay $34 million to settle a lawsuit alleging that the company…
Beeline Secures Over $426 Million in Series A Funding for Immune Drug Development
Beeline has successfully extended its Series A funding round, amassing over $426 million to further…
All of Us Program Leverages Patient Data-Sharing Networks to Enhance Real-World Data Collection
A boundary-pushing federal health research program has secured thousands of electronic medical records as it…
Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
Flamingo Pharma UK Ltd has issued a Class 3 medicines recall for specific packs of…
Relonchem Limited Issues Class 4 Medicines Defect Notification for Gabapentin Oral Solution
Relonchem Limited has notified the Medicines and Healthcare products Regulatory Agency (MHRA) of a Class…
After Monotherapy Failure, AbbVie and Genmab Tout Epkinly Combo Win in DLBCL
Despite a recent setback as a second-line monotherapy in diffuse large B-cell lymphoma (DLBCL), AbbVie…
FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
Eli Lilly, Regeneron, and Fujifilm are among the seven companies selected for the FDA’s PreCheck…
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
Talawar Therapeutics is set to make its debut on Nasdaq, raising $285 million to advance…